Xuwen Lin

机构：Beijing Shijitan Hospital

发表论文 17 篇 · 总被引 277 次 · h-index 9

代表论文

• Arbidol/IFN-α2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study (2020 · Microbes and Infection · 被引 99)
• Progresses in biomarkers for cancer immunotherapy (2023 · MedComm · 被引 47)
• Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy (2024 · Frontiers in Immunology · 被引 35)
• Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies (2024 · Clinical and Translational Medicine · 被引 20)
• New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors (2023 · Respiratory Research · 被引 15)
• Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights (2024 · Trends in cancer · 被引 14)